Table 2 Procedures and laboratory results
From: Factors associated with patency of self-expandable metal stents in malignant biliary obstruction
Procedures and laboratory results | Value |
|---|---|
Stent type | |
UC-SEMS, n (%) | 13 (11.4) |
PC-SEMS, n (%) | 88 (77.2) |
FC-SEMS, n (%) | 13 (11.4) |
Length of stent | |
6 cm, n (%) | 96 (84.2) |
8 cm, n (%) | 15 (13.2) |
10 cm, n (%) | 2 (1.8) |
12 cm, n (%) | 1 (0.9) |
Stent insertion with difficulty, n (%) | 10 (8.8) |
Percentage of diameter of stent after placement, compared with maximum diameter, median (IQR) | 51.1 (0.0, 79.9) |
Presence of stones or sludge during SEMS placement, n (%) | 23 (20.2) |
Total bilirubin before SEMS placement, mg/dL, median (IQR) | 8.3 (0.5, 32.5) |
Total bilirubin within 72 h after SEMS placement, mg/dL, median (IQR) | 3.9 (0.2, 24.2) |
Total bilirubin at 1 month after SEMS placement, mg/dL, median (IQR) | 1.6 (0.2, 29.3) |
Change of total bilirubin: within 72 h, mg/dL, median (IQR) | -3.4 (-17.7, 3.1) |
Change of total bilirubin at 1 month, mg/dL, median (IQR) | -6.0 (-31.4, 20.9) |
Concurrent tumor treatment, n (%) | 72 (63.2) |